New report highlights access gap for innovative medicines
The CAH Support Group recently provided input into a new Medicines Australia report about access to innovative medicines in Australia.
The report, now published, warns that Australian patients are missing access to some innovative medicines available in comparable countries (including medicines for babies with CAH), citing funding pressures and lengthy reimbursement processes as key factors.
Read the full report here:
https://www.medicinesaustralia.com.au/wp-content/uploads/sites/65/2026/07/03826-MA-BitterPill-Report_Accessible_Final.pdf
(Summary and title image generated using AI)Recent Blog Posts
Help Shape New UK Sick Day Guidance for Young People with Adrenal Insufficiency
Young people with adrenal insufficiency (including CAH and Addison's disease) and parents/carers are being invited to help shape new UK-wide resources on sick day rules and emergency management. The project is being led by Edge Hill University in partnership with the...
Article: Adult Quality of Life with CAH
A new study published in Endocrine Connections explores the lived experiences of adults with congenital adrenal hyperplasia (CAH) and the wide-ranging impact the condition can have on quality of life. Through in-depth interviews with adults living with CAH as well as...
Liquid Hydrocortisone Discontinued in the UK
Liquid hydrocortisone injections have been discontinued in the UK, affecting emergency treatment for people with adrenal insufficiency. This follows the supply shortage reported in February 2025 -...